CLINICAL_TRIALS
trial_result
· 2014-08-15
Clinical Trial Update: Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis [Phase 2]
Summary
Phase 2 study evaluating apremilast for rheumatoid arthritis was terminated; results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED | Results posted: 2014-08-15